Company Profile (excerpt from Reuters): The Travelers Companies, Inc., incorporated on March 5, 1853, is a holding company. The Company operates through three segments: Business and International Insurance; Bond & Specialty Insurance, and Personal Insurance. The Company, through its subsidiaries, is engaged in providing a range of commercial and personal property and casualty insurance products and services to businesses, government units, associations and individuals.
Downloadable PDF version of this valuation:
Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?
|Defensive Investor; must pass all 6 of the following tests.|
|1. Adequate Size of the Enterprise||Market Cap > $2Bil||$34,244,049,871||Pass|
|2. Earnings Stability||Positive EPS for 10 years prior||Pass|
|3. Dividend Record||Dividend Payments for 10 years prior||Pass|
|4. Earnings Growth||Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end||67.01%||Pass|
|5. Moderate PEmg Ratio||PEmg < 20||13.78||Pass|
|6. Moderate Price to Assets||PB Ratio < 2.5 OR PB*PEmg < 50||1.55||Pass|
|Enterprising Investor; must pass all 3 of the following tests, or be suitable for the Defensive Investor.|
|1. Earnings Stability||Positive EPS for 5 years prior||Pass|
|2. Dividend Record||Currently Pays Dividend||Pass|
|3. Earnings Growth||EPSmg greater than 5 years ago||Pass|
Stage 2: Determination of Intrinsic Value
|MG Growth Estimate||1.93%|
|MG Value based on 3% Growth||$136.08|
|MG Value based on 0% Growth||$79.77|
|Market Implied Growth Rate||2.64%|
|% of Intrinsic Value||111.42%|
Travelers Companies Inc qualifies for both the Defensive Investor and the Enterprising Investor. In fact, the company meets all of the requirements of both investor types, a rare accomplishment indicative of the company’s strong financial position . The Enterprising Investor has no initial concerns. As a result, all value investors following the ModernGraham approach should feel comfortable proceeding with the analysis.
As for a valuation, the company appears to be Overvalued after growing its EPSmg (normalized earnings) from $8.31 in 2014 to an estimated $9.38 for 2018. This level of demonstrated earnings growth does not support the market’s implied estimate of 2.64% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on Benjamin Graham’s formula, returns an estimate of intrinsic value below the price.
At the time of valuation, further research into Travelers Companies Inc revealed the company was trading below its Graham Number of $137.64. The company pays a dividend of $2.83 per share, for a yield of 2.2%, putting it among the best dividend paying stocks today. Its PEmg (price over earnings per share – ModernGraham) was 13.78, which was below the industry average of 32.22, which by some methods of valuation makes it one of the most undervalued stocks in its industry.
Travelers Companies Inc performs fairly well in the ModernGraham grading system, scoring a B+.
Stage 3: Information for Further Research
|Number of Consecutive Years of Dividend Growth||12|
|ModernGraham tagged articles||Morningstar|
|Google Finance||MSN Money|
|Yahoo Finance||Seeking Alpha|
Most Recent Balance Sheet Figures
|Balance Sheet Information||9/1/2018|
|Long-Term Debt & Capital Lease Obligation||$5,964,000,000|
|Shares Outstanding (Diluted Average)||268,400,000|
Earnings Per Share History
|Next Fiscal Year Estimate||$9.63|
Earnings Per Share – ModernGraham History
|Next Fiscal Year Estimate||$9.38|
Other ModernGraham posts about the company
Other ModernGraham posts about related companies
The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours. See my current holdings here. This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions. ModernGraham is not affiliated with the company in any manner. Please be sure to review our detailed disclaimer.